Dopaminergic system and monoamine oxidase-B Activity in Alzheimer's disease
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 9 (3) , 245-252
- https://doi.org/10.1016/s0197-4580(88)80061-7
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patientsNeurology, 1987
- Neuropeptides in neurological diseaseAnnals of Neurology, 1986
- A subcortico-cortical cholinergic system is affected in Parkinson's diseaseBrain Research, 1983
- Monoamine metabolism in senile dementia of Alzheimer typeJournal of the Neurological Sciences, 1983
- Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological gradingHistopathology, 1981
- Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer typeLife Sciences, 1980
- The effect of age on the activity and molecular properties of human brain monoamine oxidaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1980
- Changes in the Brain Catecholamines in Patients with Dementia of Alzheimer TypeThe British Journal of Psychiatry, 1979
- Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus MonkeyScience, 1979
- Isolation and assay of noradrenaline, dopamine, 5-hydroxy-tryptamine, and several metabolites from brain tissue using disposable bio-rad columns packed with sephadex G-10Journal of Pharmacological Methods, 1978